[ad_1] Huntington National Bank reduced its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 33.8% during the third quarter, according to the company in...
[ad_1] Bio-Rad Laboratories is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth more than $10 billion, according...